A compound of Formula (A): wherein: A is phenyl or a bicyclic heteroaryl group; X and Y are connected by a double bond and i) X is CR 7 and Y is CR 8 , ii) X is N and Y is CR 8 , or iii) X is CR 7 and Y is N; or X and Y together are C(O)NR 9 ; or X and Y are adjacent ring atoms of a 5- or 6-membered N-heterocycle fused to the aromatic ring substituted with Z, and X and Y are both C or are C and N, that is optionally substituted with one or two substituents selected from C 1 -C 3 alkyl, C 1 -C 3 fluoroalkyl, C 1 -C 3 alkoxy, Cl, F, CN, OH, OMe, OEt, NH 2 , NHMe, NMe 2 and C 1 -C 3 alkyl optionally substituted with OH, OMe, NH 2 , NHMe or NMe 2 ; Z is O, NH, orNMe; R 1 is independently selected from F, Cl, Br, OH, CH 2 OH, OMe, CH 2 OMe, C 1 -C 3 alkyl and C 1 -C 3 fluoroalkyl; n is 0, 1, 2 or 3; R 2 is H, F, Cl, CCH, CCMe, CN, Br, C 1 -C 3 alkyl, C 1 -C 3 fluoroalkyl, OMe or OEt; R 3a and R 3b together are =O or R 3a and R 3b are H; R 4 is H or Me; R 5 is H or Me; R 6 is H or CH 2 NMe 2 ; R 7 and R 8 are independently selected from H, F, Cl, CCH, CC(C 1 -C 3 alkyl), CCCH 2 NMe 2 , CCCH 2 O(C 1 -C 3 alkyl), CN, Me, C 1 -C 6 alkyl, OH, OMe, O(C 1 -C 3 alkyl), O(C 1 -C 3 deuteroalkyl), O(C 1 -C 3 fluoroalkyl), O(C 3 -C 6 cycloalkyl), C 1 -C 3 fluoroalkyl, OCH 2 CH 2 NMe 2 , OCH 2 CH 2 OMe, CH 2 OMe, OCH 2 CH 2 N(CH 2 CH 2 ) 2 CH, OCH 2 CH 2 N(CH 2 CH 2 ) 2 O, OCH 2 CH 2 (2-pyridyl) or a 3-, 4-, 5- or 6-membered carbocycle or heterocycle; or R 7 and R 8 combine to form a 5- or 6-membered carbocycle or heterocycle that is optionally substituted with one or two substituents selected from C 1 -C 3 alkyl, C 1 -C 3 fluoroalkyl, C 1 -C 3 alkoxy, Cl, F, CN, OH, OMe, OEt, NH 2 , NHMe, NMe 2 and C 1 -C 3 alkyl optionally substituted with OH, OMe, NH 2 , NHMe or NMe 2 ; R 9 is selected from H, Me, Et, C 3 H 7 and C 1 -C 3 fluoroalkyl; or a pharmaceutically acceptable salt thereof. A is phenyl or a bicyclic heteroaryl group; X and Y are connected by a double bond and i) X is CR 7 and Y is CR 8 , ii) X is N and Y is CR 8 , or iii) X is CR 7 and Y is N; or X and Y together are C(O)NR 9 ; or X and Y are adjacent ring atoms of a 5- or 6-membered N-heterocycle fused to the aromatic ring substituted with Z, and X and Y are both C or are C and N, that is optionally substituted with one or two substituents selected from C 1 -C 3 alkyl, C 1 -C 3 fluoroalkyl, C 1 -C 3 alkoxy, Cl, F, CN, OH, OMe, OEt, NH 2 , NHMe, NMe 2 and C 1 -C 3 alkyl optionally substituted with OH, OMe, NH 2 , NHMe or NMe 2 ; Z is O, NH, orNMe; R 1 is independently selected from F, Cl, Br, OH, CH 2 OH, OMe, CH 2 OMe, C 1 -C 3 alkyl and C 1 -C 3 fluoroalkyl; n is 0, 1, 2 or 3; R 2 is H, F, Cl, CCH, CCMe, CN, Br, C 1 -C 3 alkyl, C 1 -C 3 fluoroalkyl, OMe or OEt; R 3a and R 3b together are =O or R 3a and R 3b are H; R 4 is H or Me; R 5 is H or Me; R 6 is H or CH 2 NMe 2 ; R 7 and R 8 are independently selected from H, F, Cl, CCH, CC(C 1 -C 3 alkyl), CCCH 2 NMe 2 , CCCH 2 O(C 1 -C 3 alkyl), CN, Me, C 1 -C 6 alkyl, OH, OMe, O(C 1 -C 3 alkyl), O(C 1 -C 3 deuteroalkyl), O(C 1 -C 3 fluoroalkyl), O(C 3 -C 6 cycloalkyl), C 1 -C 3 fluoroalkyl, OCH 2 CH 2 NMe 2 , OCH 2 CH 2 OMe, CH 2 OMe, OCH 2 CH 2 N(CH 2 CH 2 ) 2 CH, OCH 2 CH 2 N(CH 2 CH 2 ) 2 O, OCH 2 CH 2 (2-pyridyl) or a 3-, 4-, 5- or 6-membered carbocycle or heterocycle; or R 7 and R 8 combine to form a 5- or 6-membered carbocycle or heterocycle that is optionally substituted with one or two substituents selected from C 1 -C 3 alkyl, C 1 -C 3 fluoroalkyl, C 1 -C 3 alkoxy, Cl, F, CN, OH, OMe, OEt, NH 2 , NHMe, NMe 2 and C 1 -C 3 alkyl optionally substituted with OH, OMe, NH 2 , NHMe or NMe 2 ; R 9 is selected from H, Me, Et, C 3 H 7 and C 1 -C 3 fluoroalkyl; or a pharmaceutically acceptable salt thereof. <EOS>